Safety and preliminary efficacy, pharmacokinetics ...

It was noted that the prevalence rate from the study by Strange et al (2012) was much higher than previous reports in other western countries. Peacock et al3 reported a PAH prevalence rate of 15 to 52 cases per million population, using three sources, one from France and two from Scotland. ................
................